Date: 2014-01-02
Type of information: Company acquisition
Acquired company: CeeTox (USA)
Acquiring company: Cyprotex (UK)
Amount: £0.63 million (€0.76 million)
Terms:
Details: CeeTox, based in Kalamazoo, is a Contract Research Organisation specialising in the provision of in vitro toxicological assays and screening data, principally to the Cosmetic and Personal Care Industries. Founded in 2003, CeeTox was acquired in 2005 by NAMSA, a medical research organisation supplying expert consulting, clinical and laboratory services to medical device, IVD and biologics manufacturers. NAMSA retains a license for applying CeeTox’s in vitro toxicology expertise to medical device testing. CeeTox had sales of approximately £2.3 million in the year ended 30 September 2013 and made an operating loss of approximately £0.9 million.
Related: CRO